HMGA2 and neoplasm: During EMT, HMGA2 promotes the binding of the de novo DNA methyltransferase 3A (DNMT3A) to the Cdh1 promoter, inducing the hypermethylation and silencing of the tumor-suppressor E-Cadherin (CDH1); this causes tumor cell invasion [222].